CCP (certificat complémentaire de protection), brevet(s), AMM, UE (ou Europe/EEE), Industrie Pharmaceutique, Innovation, médicament(s)

SPC in Europe: bringing reduced protection ?

Quelles sont les limites et les conditions d'application des dérogations introduites par l'entrée en vigueur du règlement modifiant le...


Participation of the patent and trademark attorney in the “saisie-contrefaçon” (infringement seizure) confirmed

A client's usual French patent and trademark attorney (Conseil en propriété industrielle) can validly participate in the saisie-contrefaçon, even...


Intellectual Property Protection and Product Registration Regulation in Biological, Pharmaceutical and Cosmetics Industries

Conference with specialists in industrial property for a better strategy in the field of biopharmaceuticals and cosmetics


Fight against counterfeiting, Chanel’s strategy in China

Chanel recently won a trademark infringement lawsuit. The case is interesting because Chanel attacked the mall and not the...

Analyses | News

PACTE bill: How will it impact IP?

The adoption of the PACTE bill on 11 April 2019 will soon lead to a number of changes with...

redevance d'une licence FRAND

“Use-based v “licence to all”: the battle to influence the workings of FRAND licences

In the field of "standard-essential patents" (SEP), which model should be adopted when setting the licence fee amount?

Subscribe to this blog